IDEXX Laboratories, Inc. (IDXX) Stock Analysis

IDEXX Laboratories, Inc. (IDXX) Stock Analysis — AI Research | MarketCI

IDXX

Market Closed

IDEXX Laboratories, Inc.

NASDAQHealthcare Medical - Diagnostics & Research

11.00K employees

CEO: Jonathan J. Mazelsky

Founded: 1991

$562.09

+$0.00(+NaN%)

Market Cap

44.34B

Beta

1.54

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

IDXX Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for IDXX built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Hold

Pass %

57.14%

Score

4/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$179.45

AI Price Target

Machine learning • Price prediction

$525.96

Market Sentiment

News & social media analysis

0.14

Value Investor Price

Classic value analysis

$38.98

Financial Health

Bankruptcy risk assessment

19.99

Quality Score

Financial strength rating

7.00

AI Investment Grade

Deep analysis of filings & news

75.00

Key Investment Highlights

Important factors affecting IDXX investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

69.23% Good

Conditions Met

27.00/39.00

Due Diligence Score

69.23%

Due Diligence Conditions

Investment analysis conditions and results


	Pass
	Pass
	Pass
	Pass
	Pass
	Pass

Showing 1 to 6 of 46 conditions